Castlight Health, inc. (NYSE:CSLT) insider Giovanni M. Colella sold 8,100 shares of Castlight Health, inc. stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $3.67, for a total transaction of $29,727.00. Following the completion of the sale, the insider now directly owns 97,969 shares of the company’s stock, valued at $359,546.23. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Shares of Castlight Health, inc. (NYSE CSLT) traded up 5.48% during mid-day trading on Friday, hitting $3.85. 212,920 shares of the stock traded hands. Castlight Health, inc. has a 52 week low of $3.05 and a 52 week high of $5.50. The company’s market cap is $506.99 million. The stock has a 50-day moving average of $4.23 and a 200-day moving average of $3.80.

Castlight Health, inc. (NYSE:CSLT) last announced its quarterly earnings results on Wednesday, August 2nd. The software maker reported ($0.07) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.09) by $0.02. Castlight Health, inc. had a negative net margin of 42.54% and a negative return on equity of 36.30%. The company had revenue of $32.10 million for the quarter, compared to analyst estimates of $31.14 million. During the same quarter in the prior year, the business posted ($0.11) EPS. Castlight Health, inc.’s quarterly revenue was up 36.0% on a year-over-year basis. Analysts anticipate that Castlight Health, inc. will post ($0.25) EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Insider Selling: Castlight Health, inc. (CSLT) Insider Sells 8,100 Shares of Stock” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.watchlistnews.com/insider-selling-castlight-health-inc-cslt-insider-sells-8100-shares-of-stock/1505280.html.

Several hedge funds and other institutional investors have recently made changes to their positions in CSLT. Oxford Asset Management acquired a new position in shares of Castlight Health, inc. during the first quarter valued at approximately $102,000. Voya Investment Management LLC raised its position in shares of Castlight Health, inc. by 25.4% in the second quarter. Voya Investment Management LLC now owns 26,929 shares of the software maker’s stock valued at $112,000 after buying an additional 5,453 shares during the period. Stifel Financial Corp raised its position in shares of Castlight Health, inc. by 4.3% in the first quarter. Stifel Financial Corp now owns 36,500 shares of the software maker’s stock valued at $133,000 after buying an additional 1,500 shares during the period. Nationwide Fund Advisors raised its position in shares of Castlight Health, inc. by 49.5% in the second quarter. Nationwide Fund Advisors now owns 36,418 shares of the software maker’s stock valued at $151,000 after buying an additional 12,061 shares during the period. Finally, FNY Partners Fund LP acquired a new position in shares of Castlight Health, inc. during the first quarter valued at approximately $164,000. Institutional investors own 40.17% of the company’s stock.

Several analysts have commented on CSLT shares. ValuEngine cut shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a research note on Thursday, August 10th. Cowen and Company reaffirmed a “market perform” rating and issued a $4.50 target price (up from $4.00) on shares of Castlight Health, inc. in a research note on Thursday, August 3rd. Dougherty & Co initiated coverage on shares of Castlight Health, inc. in a research note on Wednesday, May 10th. They set a “buy” rating and a $5.50 price objective for the company. BidaskClub cut shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a research note on Sunday, July 30th. Finally, Zacks Investment Research raised shares of Castlight Health, inc. from a “sell” rating to a “hold” rating in a research note on Tuesday, June 27th. Three research analysts have rated the stock with a sell rating, five have given a hold rating and two have issued a buy rating to the company. The stock presently has an average rating of “Hold” and a consensus price target of $4.57.

Castlight Health, inc. Company Profile

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Insider Buying and Selling by Quarter for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.